Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction

Health, Fitness & Food

Stacey Wescott | Chicago Tribune | Tribune News Service | Getty Images

Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a trial over the safety of its formula for premature babies.

Products You May Like

Articles You May Like

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Lemongrass Chicken Noodle Bowls
Running Is Inherently Political — and It’s About Time TikTok Has the Conversation
What Cramer wants to hear from Nvidia, Salesforce — plus, Lilly does what no other can
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried

Leave a Reply

Your email address will not be published. Required fields are marked *